share_log

成都欧林生物科技股份有限公司关于自愿披露四价流感病毒裂解疫苗(MDCK细胞)获得药物临床试验批准通知书的公告

Announcement of Chengdu Oulin Biotechnology Co., Ltd. on the voluntary disclosure of the quadrivalent influenza virus lytic vaccine (MDCK cells) approval notice for drug clinical trials

SZSI ·  May 15
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more